scholarly article | Q13442814 |
P2093 | author name string | Hua Zhu | |
Li-Jie Wang | |||
Ping-Sheng Cai | |||
Shu-Pin Zhu | |||
Xue-Jing Jin | |||
P2860 | cites work | ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas | Q24290531 |
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis | Q24300734 | ||
Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death | Q24630370 | ||
Inhibitors of apoptosis proteins in human cervical cancer | Q25255294 | ||
Global Variation of Human Papillomavirus Genotypes and Selected Genes Involved in Cervical Malignancies | Q26748903 | ||
Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation | Q26824586 | ||
The structure of XIAP BIR2: understanding the selectivity of the BIR domains | Q27679855 | ||
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition | Q28115131 | ||
Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins | Q28117928 | ||
Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis | Q28250529 | ||
Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib | Q33906039 | ||
The IAP family: endogenous caspase inhibitors with multiple biological activities | Q34060208 | ||
Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs. | Q35032216 | ||
Toxic proteins released from mitochondria in cell death | Q35743127 | ||
Inhibitor of apoptosis proteins and apoptosis | Q37134050 | ||
Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma | Q37214207 | ||
IAP-targeted therapies for cancer | Q37302745 | ||
XIAP: a potential determinant of ovarian follicular fate | Q38015241 | ||
Tissue biomarkers as prognostic variables of cervical cancer | Q38048996 | ||
2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors | Q38091972 | ||
Human papillomavirus oncoproteins and apoptosis (Review). | Q38172151 | ||
IAPs, regulators of innate immunity and inflammation. | Q38203437 | ||
IAP family of cell death and signaling regulators | Q38234366 | ||
The role of signaling pathways in cervical cancer and molecular therapeutic targets. | Q38275732 | ||
Smac mimetics as IAP antagonists | Q38304312 | ||
Smad4 deficiency in cervical carcinoma cells. | Q38334502 | ||
Cancer hallmarks in induced pluripotent cells: new insights | Q38570169 | ||
Smac-Derived Aza-Peptide As an Aminopeptidase-Resistant XIAP BIR3 Antagonist | Q38843018 | ||
The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cells | Q39195579 | ||
Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas | Q40392805 | ||
Functional evaluation of the role of inhibitor of apoptosis proteins in chronic lymphocytic leukemia | Q40548205 | ||
Intramitochondrial recruitment of endolysosomes mediates Smac degradation and constitutes a novel intrinsic apoptosis antagonizing function of XIAP E3 ligase. | Q42085320 | ||
Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. | Q42505005 | ||
Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression | Q42968932 | ||
Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro | Q44066914 | ||
Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells | Q44762625 | ||
Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value | Q46961534 | ||
Predictors of clinical breast examination among South Asian immigrant women | Q47328273 | ||
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo | Q48548442 | ||
2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. | Q53248089 | ||
Overexpression of anti-apoptotic gene BAG-1 in human cervical cancer. | Q53425981 | ||
Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma. | Q54572875 | ||
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer | Q57089342 | ||
[WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics] | Q73150850 | ||
Revised FIGO staging for carcinoma of the cervix | Q83602025 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5340-5346 | |
P577 | publication date | 2017-09-04 | |
P1433 | published in | Oncology Letters | Q20640514 |
P1476 | title | Negative correlation between X-linked inhibitors of apoptosis and second mitochondria-derived activator of caspase expression levels in cervical carcinoma and cervical intraepithelial neoplasia | |
P478 | volume | 14 |
Search more.